## Abstract The presence of clonally restricted B lymphocytes in the peripheral blood of patients with multiple sclerosis (MS) was investigated using a cytofluorometric technique able to detect lymphocytes having homogeneous amounts of surface immunoglobulin of one light chain class. Thirtyโfive of
Analysis of tumor-specific immunoglobulin gene rearrangement in peripheral blood B-cells of multiple myeloma patients
โ Scribed by Dr. L. Baldini; L. Cro; D. Delia; O. Chiorboli; A. Neri; A. T. Maiolo
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 446 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Several sensitive surveillance tests reportedly have been used to detect occult neuroblastoma (nb) cells in peripheral blood (pb) and bone marrow (bm). they may be useful in monitoring minimal residual tumor cells. the authors report the feasibility and clinical usefulness of a sensi
The blood of multiple myeloma patients was examined for non-MHC-restricted cytotoxic lymphocytes. Four colour flow cytometry was used to phenotype the cells within a light scatter gate large enough to include all lymphocytes. NK and T cells were identified using CD16, CD56, and CD3 antibodies, and m
A study was performed to investigate the utility of polymerase chain reaction (PCR)-based analysis of immunoglobulin heavy chain (IgH) gene rearrangements for the diagnosis of low-grade malignant B-cell lymphomas on formalin-ยฎxed, EDTA-decalciยฎed, and parafยฎn-embedded bone marrow trephine biopsies.
Non-small-cell lung cancers (NSCLC) are often infiltrated by T lymphocytes. It is postulated that the presence of tumor-infiltrating lymphocytes (TIL) reflects a local host immune response against autologous tumors. To identify the nature of NSCLC TIL, we have characterized the molecular structure o
## Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer To the Editor: The presence of circulating tumor cells (CTC) in the peripheral blood of cancer patients has attracted a great deal of attention among invest